Literature DB >> 25057897

Anionic polycyclization entry to tricycles related to quassinoids and terpenoids: a stereocontrolled total synthesis of (+)-cassaine.

Kontham Ravindar1, Pierre-Yves Caron, Pierre Deslongchamps.   

Abstract

A full account of our anionic polycyclization approach to access highly functionalized tricycles related to quassinoids and terpenoids from several optically active bicyclic enone systems and Nazarov reagents is presented. (+)-Carvone is the only chiral source used to fix the entire stereochemistry of all of the tricycles, and the stereochemical outcome of this process was unambiguously determined by X-ray crystallographic analysis. The utility of this strategy was demonstrated by the stereocontrolled construction of advanced tricycles related to the highly potent anticancer natural product bruceantin, a member of quassinoid family, and the total synthesis of the cardioactive terpenoid (+)-cassaine, a nonsteroidal inhibitor of Na(+)-K(+)-ATPase.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25057897     DOI: 10.1021/jo501122k

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Enantioselective synthesis of cis-decalins using organocatalysis and sulfonyl Nazarov reagents.

Authors:  Javier Peña; Gastón Silveira-Dorta; Rosalina F Moro; Narciso M Garrido; Isidro S Marcos; Francisca Sanz; David Díez
Journal:  Molecules       Date:  2015-04-10       Impact factor: 4.411

2.  Quassinoids from the Roots of Eurycoma longifolia and Their Anti-Proliferation Activities.

Authors:  Wei-Qun Yang; Wei Tang; Xiao-Jun Huang; Jian-Guo Song; Yue-Yue Li; Yu Xiong; Chun-Lin Fan; Zhen-Long Wu; Ying Wang; Wen-Cai Ye
Journal:  Molecules       Date:  2021-09-30       Impact factor: 4.411

Review 3.  A Synthetic View on Momilactones and Related 9β-H Pimarane Skeleton Diterpenoids.

Authors:  Yue Zhang; Mengran Li; Qichang Liu; Jian Huang; Yang Chen
Journal:  Front Chem       Date:  2022-03-21       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.